Multitarget tyrosine kinase inhibitor treatment in novel patient-derived mesothelioma cell lines
Main Author: | Szűcs Kata Dorina |
---|---|
Other Authors: |
Escudero Vinolo, Marcos, PhD
Carballeira López, Pablo, PhD |
Format: | Manuscript essay |
Published: |
2022-01-27
|
Online Access: | https://diplomamunka.ppke.hu/8521 |
Similar Items
-
The role of genetic factors in cell migration in mesothelioma cell lines
by: Dobos Nikolett Kitti
Published: (2025) -
Verification of brain penetration of the unbound fraction of a novel HER2/EGFR dual kinase inhibitor (TAK-285) by microdialysis in rats.
by: Erdő Franciska, et al.
Published: (2012) -
Mesenchymal stem cell-derived extracellular vesicles for cardioprotection against cytotoxic drugs
by: Dánél Dorottya
Published: (2025) -
MAP Kinase-Mediated Activation of RSK1 and MK2 Substrate Kinases
by: Sok Péter Dániel, et al.
Published: (2020) -
The role of extracellular vesicles in the emergence of vemurafenib resistance in melanoma cell lines
by: Izsó Blanka Judit
Published: (2014)